174 related articles for article (PubMed ID: 24515446)
1. Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?
Perez-Alamino R; Garcia-Valladares I; Cuchacovich R; Iglesias-Gamarra A; Espinoza LR
Rheumatol Int; 2014 Sep; 34(9):1211-6. PubMed ID: 24515446
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to cyclic citrullinated peptides in psoriatic arthritis.
Bogliolo L; Alpini C; Caporali R; Scirè CA; Moratti R; Montecucco C
J Rheumatol; 2005 Mar; 32(3):511-5. PubMed ID: 15742445
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation.
Alenius GM; Berglin E; Rantapää Dahlqvist S
Ann Rheum Dis; 2006 Mar; 65(3):398-400. PubMed ID: 16096328
[TBL] [Abstract][Full Text] [Related]
5. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.
Vander Cruyssen B; Hoffman IE; Zmierczak H; Van den Berghe M; Kruithof E; De Rycke L; Mielants H; Veys EM; Baeten D; De Keyser F
Ann Rheum Dis; 2005 Aug; 64(8):1145-9. PubMed ID: 15695535
[TBL] [Abstract][Full Text] [Related]
6. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
Inanc N; Dalkilic E; Kamali S; Kasapoglu-Günal E; Elbir Y; Direskeneli H; Inanc M
Clin Rheumatol; 2007 Jan; 26(1):17-23. PubMed ID: 16538391
[TBL] [Abstract][Full Text] [Related]
7. Anti-cyclic citrullinated peptide antibodies in psoriatic arthritis--cross-sectional study and literature review.
Popescu C; Zofotă S; Bojincă V; Ionescu R
J Med Life; 2013; 6(4):376-82. PubMed ID: 24701255
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against cyclic citrullinated peptide in Japanese psoriatic arthritis patients.
Maejima H; Aki R; Watarai A; Shirai K; Hamada Y; Katsuoka K
J Dermatol; 2010 Apr; 37(4):339-45. PubMed ID: 20507403
[TBL] [Abstract][Full Text] [Related]
9. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody].
Dai LY; Gong DD; Zhao JX
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1008-1013. PubMed ID: 31848495
[TBL] [Abstract][Full Text] [Related]
11. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis.
Shibata S; Tada Y; Komine M; Hattori N; Osame S; Kanda N; Watanabe S; Saeki H; Tamaki K
J Dermatol Sci; 2009 Jan; 53(1):34-9. PubMed ID: 18752933
[TBL] [Abstract][Full Text] [Related]
12. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis.
Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
Clin Exp Rheumatol; 2007; 25(4):599-604. PubMed ID: 17888217
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History.
Jadon DR; Shaddick G; Tillett W; Korendowych E; Robinson G; Waldron N; Cavill C; McHugh NJ
J Rheumatol; 2015 Jul; 42(7):1169-76. PubMed ID: 25979723
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions.
Narváez J; Sirvent E; Narváez JA; Bas J; Gómez-Vaquero C; Reina D; Nolla JM; Valverde J
Semin Arthritis Rheum; 2008 Oct; 38(2):101-9. PubMed ID: 18221987
[TBL] [Abstract][Full Text] [Related]
17. Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis.
Hagiwara S; Tsuboi H; Terasaki T; Terasaki M; Toko H; Shimizu M; Honda F; Yagishita M; Ohyama A; Takahashi H; Yokosawa M; Asashima H; Kondo Y; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Mar; 30(2):365-372. PubMed ID: 30794003
[No Abstract] [Full Text] [Related]
18. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
19. Laboratory findings in psoriatic arthritis.
Punzi L; Podswiadek M; Oliviero F; Lonigro A; Modesti V; Ramonda R; Todesco S
Reumatismo; 2007; 59 Suppl 1():52-5. PubMed ID: 17828345
[TBL] [Abstract][Full Text] [Related]
20. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
Mouterde G; Lukas C; Goupille P; Flipo RM; Rincheval N; Daurès JP; Combe B
J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
